ドライアイ治療薬市場レポート：2031年までの動向、予測、競合分析

世界のドライアイ治療薬市場の将来性は、病院薬局、眼科クリニック、小売薬局、オンライン薬局の各市場における機会によって有望視されています。世界のドライアイ治療薬市場は、2025年から2031年にかけてCAGR 3.5％で成長すると予想されます。この市場の主な促進要因は、ドライアイの有病率の高まりと眼病患者の増加です。

• Lucintel社の予測によると、製品タイプ別では、水薬が予測期間中に最も高い成長を遂げる見込みです。
• 最終用途別では、病院薬局が最も高い成長が見込まれます。
• 地域別では、北米が予測期間中に最も高い成長が見込まれます。

ドライアイ治療薬市場の戦略的成長機会

ドライアイ治療薬市場の成長は、さまざまな応用分野にわたっていくつかの要因によって促進されています。これらの成長機会は治療を改善し、患者の予後改善につながります。ここでは、これらの市場における5つの重要な機会を紹介します：

• 医薬品開発の革新：新しい治療法に対する現代的なニーズは相当なものであり、これは大きなチャンスとなります。製薬会社は、ドライアイ症候群の症状や原因をより効果的に緩和する新しい化合物を設計することができます。
• より多くの処方薬およびOTC製品の導入：ドライアイ症候群の有病率の増加に伴い、処方薬や一般用医薬品（OTC）の種類を増やす機会があります。安価で効果的な点眼薬や潤滑剤を製造するのは比較的容易であり、消費者はそれを購入することですぐに症状を緩和することができます。
• 遠隔医療の機会の改善：遠隔医療が成長し続ける中、患者との関わりを改善し、治療へのアクセスを提供する機会があります。ドライアイ管理のための遠隔診療を可能にする使いやすいモバイルアプリを作成することは、農村部や十分な診療を受けていない人々にとって特に有益です。
• 臨床試験への投資：臨床試験における新たな治療法の開発に努力と資源を集中させることは、ドライアイ治療薬の市場成長を促進します。治療効果を高める研究や技術革新を重視する企業は、既存のギャップに対処することで市場基盤を拡大することができます。
• ヘルスケア機関とのパートナーシップ：医療専門家と連携して教育プログラムを作成・提供することで、ドライアイに対する認識と知識を高めることができます。このようなプログラムは、早期診断とより良い治療の助けとなり、患者と医薬品メーカーの双方に利益をもたらします。

このような成長機会は、治療の選択肢を広げ、患者へのアクセスを向上させ、さらなる研究を促すことで、ドライアイ治療薬市場の将来を形成しています。

ドライアイ治療薬市場の促進要因・課題

ドライアイ治療薬市場が成長と成熟を目指す中で、影響を及ぼす技術的、経済的、規制的な要因や市場がいくつかあります。これらの市場促進要因・課題は、特に現在進行中の市場の急速な進化において、利害関係者にとって非常に重要です。

ドライアイ治療薬市場を牽引する要因は以下の通り：

• 技術の進歩：技術の進歩：ドライアイ症候群の治療を目的とした医薬品の製剤と送達方法の両方が進歩することで、楽しいコンテンツが受け取りやすくなります。防腐剤フリーの点眼薬や徐放性システムなどの新しい治療法は、患者のアドヒアランスと治療費効率を高めるため、市場の拡大に貢献します。
• 認識と診断の高まり：ドライアイ症候群の診断率が低いのは、国民やヘルスケアプロバイダーがリスク要因を特定できないためです。公衆衛生キャンペーンは、患者が症状を特定するのに役立つ情報を提供することで、治療を求める行動と市場拡大を促進します。
• ドライアイ症候群の有病率の上昇：ドライアイ症候群はますます一般的になってきていますが、これはコンピューター画面の使用増加や環境などの生活習慣に起因しています。このような罹患率の増加は、効果的な治療を提供する市場を生み出し、市場の成長に寄与しています。
• 支持的な規制環境：当局は、新薬の上市を迅速に進めるための新たな方法や、新規の治療法についてスポンサー企業に好意的です。このため、製薬企業による新薬の研究開発が活発化し、最終的には患者にとって治療の選択肢が増えることになります。
• 調査投資の増加：ドライアイ治療薬の市場開拓に道を開く研究開発には、継続的な重点が置かれています。製薬会社は、一般的な薬剤や新規薬剤、新しい治療スキームを応用して、現在の薬剤の症例を改善し、既存の欠陥に対応しています。

ドライアイ治療薬市場における課題は以下の通り：

• 革新的治療法の高コスト：新しく効果的な治療法の高額な費用は、一部の患者にとって障壁となる可能性があります。高額な治療は患者のコンプライアンスを低下させ、治療の適用範囲を制限し、健康状態の悪化を招く可能性があります。
• 限られた患者の認識：医療従事者のトレーニングが改善されたにもかかわらず、一部の患者はドライアイ症候群や利用可能な治療法についての認識がまだ不十分です。そのため、タイムリーな診断と適切な治療が制限され、市場成長の妨げとなっています。
• 規制上のハードル：規制当局は技術革新を支援していますが、企業は審査に長時間を要し、要件が厳しいため、製品の承認取得に課題を抱えています。このような遅延は新しい治療法の導入に必要な時間を延長し、市場力学に影響を与える可能性があります。

ドライアイ治療薬市場は、これらの促進要因・課題の相互作用によって形成されています。市場促進要因を活用し、課題を軽減することで、患者のケアを改善し、治療の可能性を高め、市場の成長を促すことができます。

目次

第1章 エグゼクティブサマリー

第2章 世界のドライアイ治療薬市場：市場力学

• イントロダクション、背景、分類
• サプライチェーン
• 業界の促進要因と課題

第3章 2019年から2031年までの市場動向と予測分析

• マクロ経済動向（2019～2024年）と予測（2025-2031年）
• 世界のドライアイ治療薬市場の動向（2019～2024年）と予測（2025～2031年）
• 製品タイプ別：ドライアイ治療薬の世界市場
  • 水性
  • 蒸発性
  • 水性および蒸発性
• 投与システム別：ドライアイ治療薬の世界市場
  • 液体
  • ゲル
  • 軟膏
  • その他
• 処方タイプ別：ドライアイ治療薬の世界市場
  • 市販薬
  • 処方薬
• 最終用途別：ドライアイ治療薬の世界市場
  • 病院薬局
  • アイヘルスクリニック
  • 小売薬局
  • オンライン薬局

第4章 2019年から2031年までの地域別市場動向と予測分析

• 地域別：ドライアイ治療薬の世界市場
• 北米のドライアイ治療薬市場
• 欧州のドライアイ治療薬市場
• アジア太平洋地域のドライアイ治療薬市場
• その他地域ドライアイ治療薬市場

第5章 競合分析

• 製品ポートフォリオ分析
• 運用統合
• ポーターのファイブフォース分析

第6章 成長機会と戦略分析

• 成長機会分析
  • 製品タイプ別：世界のドライアイ治療薬市場の成長機会
  • 投与システム別：世界のドライアイ治療薬市場の成長機会
  • 処方タイプ別：世界のドライアイ治療薬市場の成長機会
  • 最終用途別：世界のドライアイ治療薬市場の成長機会
  • 地域別：世界のドライアイ治療薬市場の成長機会
• 世界のドライアイ治療薬市場の新たな動向
• 戦略分析
  • 新製品開発
  • 世界のドライアイ治療薬市場の生産能力拡大
  • 世界のドライアイ治療薬市場における合併、買収、合弁事業
  • 認証とライセンシング

第7章 主要企業の企業プロファイル

• Allergan
• Alcon
• Bausch Health Companies
• Novartis
• Otsuka Holdings
• Santen Pharmaceutical
• Sentiss Pharma
• OASIS Medical
• VISUfarma
• Sun Pharmaceutical

The future of the global dry eye medication market looks promising with opportunities in the hospital pharmacy, eye health clinic, retail pharmacy, and online pharmacy markets. The global dry eye medication market is expected to grow with a CAGR of 3.5% from 2025 to 2031. The major drivers for this market are the growing prevalence of the disease and increasing cases of eye diseases.

• Lucintel forecasts that, within the type of product category, aqueous is expected to witness the highest growth over the forecast period.
• Within the end use category, hospital pharmacy is expected to witness the highest growth.
• In terms of regions, North America is expected to witness the highest growth over the forecast period.

Gain Valuable insights for your business decisions with our comprehensive 150+ page report.

Emerging Trends in the Dry Eye Medication Market

The dry eye medication market is witnessing multiple evolving trends that are considerably affecting its future. Here are five key trends currently influencing the landscape:

• Emerging Practice of Targeted Approaches: Personalized treatment is on the rise for dry eye syndrome. Providing specific treatments based on particular symptoms and the root pathology of the disease increases response rates. In turn, this trend motivates health professionals to perform appropriate investigations that will, in the long run, yield good results due to well-focused treatments and management.
• Emergence of Novel Drug Delivery Systems: New forms of drug delivery, such as microemulsions and sustained-release systems, are emerging in the dry eye market. These technologies increase the availability and efficiency of medications, providing longer relief from signs and symptoms. Children and elderly patients may also benefit more from these advanced delivery systems, minimizing the inconvenience of frequent dosing and improving compliance.
• Increase in the Need for Bottle-free Formulations: Due to the irritation and toxicity associated with preservatives such as benzalkonium chloride, there is an increasing demand for preservative-free eye drops among consumers. As a result, manufacturers are aiming at creating safe, preservative-free products that help patients manage dry eye while ensuring their comfort.
• Telemedicine Adoption: The incorporation of telemedicine in the treatment of dry eye disease is changing patients' outlook on how to seek treatment for the condition. During virtual consultations, patients do not need to visit a clinic to receive advice and prescriptions, thus increasing the geographic accessibility of care. This trend improves patient compliance and the management of long-term conditions.
• Increased Research and Development Activities: Investments in research activities related to dry eye therapies have begun to bear fruit, leading to innovations. Pharmaceutical companies are exploring new compounds, technologies, and treatment options, which are beneficial as they offer more effective choices. This trend is important for meeting consumer needs and enhancing the level of care in the dry eye market.

These new trends strengthen solution effectiveness, patient adherence and tolerance, and drug delivery innovation in the dry eye medication industry. Over time, these trends will assist patients in better managing dry eye syndrome, thus improving their quality of life.

Recent Developments in the Dry Eye Medication Market

Recent market developments in dry eye medication indicate that new treatments for patients with this condition are emerging. These developments significantly enhance patient benefits and management of dry eye syndrome. Here are five key developments shaping the market:

• New Therapeutics Approved: These include eye adherence formulations such as prescription eye drops, which reduce inflammation and increase tear production. These innovations allow patients who have not found relief using conventional methods to access less invasive techniques for adequate symptom control.
• Emergence of Smart Contact Lenses: Smart contact lenses with dry eye medication capabilities and features that allow for a slow release of drugs represent another major progress in the field. This novel approach offers continuous control of dry eye symptoms with little need for frequent application of eye drops, thus improving patient compliance.
• Investment in Research: Increased investment in research and development is driving positive changes in the dry eye medication market. Current efforts aim to reveal the possible pathophysiology of dry eye disorder, thereby expanding therapeutic opportunities with new oil structures and more effective treatments.
• Increase in the Utilization of Telerehabilitation Services: Advancements in telehealth services enable patients affected by dry eye syndrome to receive adequate care. Virtual consultations make it possible for caregivers to follow up with patients and adjust treatment plans remotely, boosting patient involvement and improving the management of the condition.
• Educational Activities Directed Toward Health Care Practitioners: Systematic education of health care practitioners is raising awareness and understanding of dry eye syndrome. Enhanced training improves how patients are assessed, managed, and treated, leading to better care.

These central developments are poised to significantly benefit the growth of the dry eye medication market by introducing new treatment options, making treatment more accessible, and encouraging further research. These innovations will continue to advance the field of dry eye treatments as the industry evolves.

Strategic Growth Opportunities for Dry Eye Medication Market

Several factors are driving the growth of the dry eye medication market across various application areas. These growth opportunities can improve treatment and lead to better patient outcomes. Here are five key opportunities in these markets:

• Innovation in Drug Development: There is a substantial contemporary need for new therapies, which presents a significant opportunity. Pharmaceutical companies can design new medical compounds that more effectively relieve the symptoms and causes of dry eye syndrome.
• Introduction of More Prescription and OTC Products: With the increasing prevalence of dry eye syndrome, there are opportunities to expand the range of prescription and over-the-counter (OTC) products. It is relatively easy to manufacture inexpensive yet effective eye drops and lubricants that consumers can purchase for immediate relief.
• Improvement in Telemedicine Opportunities: As telemedicine continues to grow, there are opportunities to improve patient engagement and provide access to care. Creating easy-to-use mobile apps that enable remote consultations for dry eye management can be particularly beneficial for rural and underserved populations.
• Clinical Trial Investment: Focusing efforts and resources on developing new treatment options in clinical trials can fuel market growth for dry eye medications. Firms that emphasize research and innovations that improve treatment efficacy will expand their market base by addressing existing gaps.
• Partnerships with Healthcare Institutions: Engaging with medical professionals to create and deliver educational programs can help increase awareness and knowledge about dry eye disease. These programs can assist in earlier diagnosis and better treatment, benefiting both patients and drug manufacturers.

These growth opportunities are shaping the future of the dry eye medication market by expanding treatment options, increasing patient access, and encouraging further research.

Dry Eye Medication Market Driver and Challenges

There are several technological, economic, and regulatory factors and markets that influence the dry eye medication market as it seeks to grow and mature. These drivers and challenges are very important for the stakeholders, especially in this speedy evolution of the market that is ongoing.

The factors responsible for driving the dry eye medication market include:

• Technological Advancements: Enjoyable content will become easier to receive, through advances in both formulations and delivery methods of pharmaceuticals which are aimed at treating dry eye syndrome. New therapies including preservative-free eye drops and sustained-release systems increase the adherence and treatment cost efficiency for patients and therefore help to increase the market.
• Growing Awareness and Diagnosis: Low diagnosis rates of dry eye syndrome have been attributed to the unidentifiable risk factor among the populace and the healthcare providers. Public health campaigns facilitate treatment-seeking behavior and market expansion by providing information to assist patients in the identification of symptoms of the condition.
• Rising Prevalence of Dry Eye Syndrome: Dry eye syndrome has become increasingly commonplace which can be attributed to some lifestyle habits such as increased use of computer screens and the environment. This growing incidence creates a market for the provision of these effective treatments hence contributing to the growth of the market.
• Supportive Regulatory Environment: Authorities have become favorable for the sponsoring companies on new and novel therapies and new ways for fast-tracking the putting of new drugs on the market. This leads to more research and development for new drugs among pharmaceutical companies which eventually leads to more options for patients in terms of treatment.
• Increased Investment in Research: There is a continued focus on research and development that is paving the way for new developments in the market of dry eye medications. Pharmaceutical companies are applying common and novel drugs and new treatment schemes to improve current cases of drugs and cater to existing deficiencies.

Challenges in the dry eye medication market are:

• High Cost of Innovative Treatments: The high cost of new, effective therapies can be a barrier for some patients. Expensive treatments may erode patient compliance and limit treatment coverage, leading to poorer health outcomes.
• Limited Patient Awareness: Despite improvements in healthcare provider training, some patients still lack awareness of dry eye syndrome and available treatment options. This limits timely diagnosis and appropriate treatment, hindering market growth.
• Regulatory Hurdles: While regulatory authorities support innovation, companies face challenges in getting products approved due to lengthy review times and stringent requirements. These delays can extend the time needed to introduce new therapies, affecting market dynamics.

The interplay between these drivers and challenges shapes the dry eye medication market. By leveraging the drivers and mitigating the challenges, patient care can be improved, treatment availability can increase, and market growth can be stimulated.

List of Dry Eye Medication Companies

Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. Through these strategies dry eye medication companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the dry eye medication companies profiled in this report include-

• Allergan
• Alcon
• Bausch Health Companies
• Novartis
• Otsuka Holdings
• Santen Pharmaceutical
• Sentiss Pharma
• OASIS Medical
• VISUfarma
• Sun Pharmaceutical

Dry Eye Medication by Segment

The study includes a forecast for the global dry eye medication market by type of product, delivery system, prescription type, end use, and region.

Dry Eye Medication Market by Type Of Product [Analysis by Value from 2019 to 2031]:

• Aqueous
• Evaporative
• Aqueous and Evaporative

Dry Eye Medication Market by Delivery System [Analysis by Value from 2019 to 2031]:

• Liquid
• Gel
• Ointment
• Others

Dry Eye Medication Market by Prescription Type [Analysis by Value from 2019 to 2031]:

• OTC Drugs
• Prescription Drugs

Dry Eye Medication Market by End Use [Analysis by Value from 2019 to 2031]:

• Hospital Pharmacy
• Eye Health Clinic
• Retail Pharmacy
• Online Pharmacy

Dry Eye Medication Market by Region [Analysis by Value from 2019 to 2031]:

• North America
• Europe
• Asia Pacific
• The Rest of the World

Country Wise Outlook for the Dry Eye Medication Market

The global dry eye medication market has advanced significantly, driven by a growing understanding of the disease and the increasing availability of new treatment alternatives. With changing lifestyles, especially the increased use of electronic devices, dry eye syndrome has become more prevalent, prompting the pharmaceutical industry to develop better therapies. The United States, China, Germany, India, and Japan are at the forefront of product development, regulation, and the launch of new products aimed at alleviating dry eye symptoms.

• United States: In the U.S., the dry eye medication market is expanding with the approval of new therapies, including prescription eye drops containing cyclosporine A and lifitegrast. These therapies reduce inflammation and improve tear production. There is also growing interest in smart contact lenses that release medication over time. Increased awareness initiatives are helping people identify symptoms and treatment options, leading to more diagnoses. Telemedicine is also making it easier for patients with chronic dry eye to access care from eye care professionals.
• China: The dry eye medication market in China is growing as awareness increases, particularly in urban areas. Government health promotions are improving the diagnosis of dry eye syndrome, and local developers are producing inexpensive OTC eye drops. Partnerships between global and local companies have accelerated access to new treatments and technologies. There is also a growing trend toward preservative-free formulations to enhance patient comfort.
• Germany: Germany is the leading market for dry eye medications in Europe, with a strong emphasis on research and development. Expanding therapeutic indications are driving the development of new therapeutics, including anti-inflammatory and regenerative eye drops. Supportive regulatory bodies facilitate the approval of new products. Additionally, targeted educational programs for healthcare professionals are improving diagnosis and treatment. Personalized medicine, which tailors treatments to individual patient needs, is also being explored.
• India: In India, the dry eye medication market is changing as awareness grows and the prevalence of the condition rises. Domestic companies are launching affordable preservative-free and herbal eye drops to meet the needs of different patient groups. Increased training for healthcare professionals has led to more diagnoses of dry eye disease. The use of telehealth services is growing, improving access to eye care providers, especially in rural areas. Collaborations between drug companies and academic institutions are also advancing treatment options.
• Japan: In Japan, the dry eye medication market is marked by a focus on advanced research and high standards of care. New interventions, such as tear substitutes and anti-inflammatory therapies, are promoting effective treatment. Japan has also developed sustained-release systems, such as insertion devices, to treat dry eye symptoms. Government support for research into the contributing factors of dry eye disease is fostering innovation. Public education campaigns are helping patients access care more easily.

Features of the Global Dry Eye Medication Market

Market Size Estimates: Dry eye medication market size estimation in terms of value ($B).

Trend and Forecast Analysis: Market trends (2019 to 2024) and forecasts (2025 to 2031) by various segments and regions.

Segmentation Analysis: Dry eye medication market size by various segments, such as by type of product, delivery system, prescription type, end use, and region in terms of value ($B).

Regional Analysis: Dry eye medication market breakdown by North America, Europe, Asia Pacific, and Rest of the World.

Growth Opportunities: Analysis of growth opportunities in different type of product, delivery system, prescription type, end use, and regions for the dry eye medication market.

Strategic Analysis: This includes M&A, new product development, and competitive landscape of the dry eye medication market.

Analysis of competitive intensity of the industry based on Porter's Five Forces model.

If you are looking to expand your business in this market or adjacent markets, then contact us. We have done hundreds of strategic consulting projects in market entry, opportunity screening, due diligence, supply chain analysis, M & A, and more.

This report answers following 11 key questions:

• Q.1. What are some of the most promising, high-growth opportunities for the dry eye medication market by type of product (aqueous, evaporative, and aqueous and evaporative), delivery system (liquid, gel, ointment, and others), prescription type (OTC drugs and prescription drugs), end use (hospital pharmacy, eye health clinic, retail pharmacy, and online pharmacy), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
• Q.2. Which segments will grow at a faster pace and why?
• Q.3. Which region will grow at a faster pace and why?
• Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
• Q.5. What are the business risks and competitive threats in this market?
• Q.6. What are the emerging trends in this market and the reasons behind them?
• Q.7. What are some of the changing demands of customers in the market?
• Q.8. What are the new developments in the market? Which companies are leading these developments?
• Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
• Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
• Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?

Table of Contents

1. Executive Summary

2. Global Dry Eye Medication Market : Market Dynamics

• 2.1: Introduction, Background, and Classifications
• 2.2: Supply Chain
• 2.3: Industry Drivers and Challenges

3. Market Trends and Forecast Analysis from 2019 to 2031

• 3.1. Macroeconomic Trends (2019-2024) and Forecast (2025-2031)
• 3.2. Global Dry Eye Medication Market Trends (2019-2024) and Forecast (2025-2031)
• 3.3: Global Dry Eye Medication Market by Type of Product
  • 3.3.1: Aqueous
  • 3.3.2: Evaporative
  • 3.3.3: Aqueous and Evaporative
• 3.4: Global Dry Eye Medication Market by Delivery System
  • 3.4.1: Liquid
  • 3.4.2: Gel
  • 3.4.3: Ointment
  • 3.4.4: Others
• 3.5: Global Dry Eye Medication Market by Prescription Type
  • 3.5.1: OTC Drugs
  • 3.5.2: Prescription Drugs
• 3.6: Global Dry Eye Medication Market by End Use
  • 3.6.1: Hospital Pharmacy
  • 3.6.2: Eye Health Clinic
  • 3.6.3: Retail Pharmacy
  • 3.6.4: Online Pharmacy

4. Market Trends and Forecast Analysis by Region from 2019 to 2031

• 4.1: Global Dry Eye Medication Market by Region
• 4.2: North American Dry Eye Medication Market
  • 4.2.1: North American Market by Type of Product: Aqueous, Evaporative, and Aqueous and Evaporative
  • 4.2.2: North American Market by End Use: Hospital Pharmacy, Eye Health Clinic, Retail Pharmacy, and Online Pharmacy
• 4.3: European Dry Eye Medication Market
  • 4.3.1: European Market by Type of Product: Aqueous, Evaporative, and Aqueous and Evaporative
  • 4.3.2: European Market by End Use: Hospital Pharmacy, Eye Health Clinic, Retail Pharmacy, and Online Pharmacy
• 4.4: APAC Dry Eye Medication Market
  • 4.4.1: APAC Market by Type of Product: Aqueous, Evaporative, and Aqueous and Evaporative
  • 4.4.2: APAC Market by End Use: Hospital Pharmacy, Eye Health Clinic, Retail Pharmacy, and Online Pharmacy
• 4.5: ROW Dry Eye Medication Market
  • 4.5.1: ROW Market by Type of Product: Aqueous, Evaporative, and Aqueous and Evaporative
  • 4.5.2: ROW Market by End Use: Hospital Pharmacy, Eye Health Clinic, Retail Pharmacy, and Online Pharmacy

5. Competitor Analysis

• 5.1: Product Portfolio Analysis
• 5.2: Operational Integration
• 5.3: Porter's Five Forces Analysis

6. Growth Opportunities and Strategic Analysis

• 6.1: Growth Opportunity Analysis
  • 6.1.1: Growth Opportunities for the Global Dry Eye Medication Market by Type of Product
  • 6.1.2: Growth Opportunities for the Global Dry Eye Medication Market by Delivery System
  • 6.1.3: Growth Opportunities for the Global Dry Eye Medication Market by Prescription Type
  • 6.1.4: Growth Opportunities for the Global Dry Eye Medication Market by End Use
  • 6.1.5: Growth Opportunities for the Global Dry Eye Medication Market by Region
• 6.2: Emerging Trends in the Global Dry Eye Medication Market
• 6.3: Strategic Analysis
  • 6.3.1: New Product Development
  • 6.3.2: Capacity Expansion of the Global Dry Eye Medication Market
  • 6.3.3: Mergers, Acquisitions, and Joint Ventures in the Global Dry Eye Medication Market
  • 6.3.4: Certification and Licensing

7. Company Profiles of Leading Players

• 7.1: Allergan
• 7.2: Alcon
• 7.3: Bausch Health Companies
• 7.4: Novartis
• 7.5: Otsuka Holdings
• 7.6: Santen Pharmaceutical
• 7.7: Sentiss Pharma
• 7.8: OASIS Medical
• 7.9: VISUfarma
• 7.10: Sun Pharmaceutical